Detection windows · opioid
Fentanyl detection windows
Fentanyl is a potent synthetic opioid. SAMHSA added fentanyl and its metabolite norfentanyl to the federal urine and oral-fluid panels effective July 7, 2025, reflecting its role in the overdose crisis. It is also detected on most expanded clinical panels.
Last updated:How long is Fentanyl detectable?
Detection windows for Fentanyl vary by specimen, use pattern, and individual factors. As approximate ranges: urine commonly covers a few days (longer in chronic users), oral fluid covers hours to about 48 hours, blood covers hours, and hair offers up to ~90 days after a ~7–10 day incorporation delay. Full matrix below — and see the interactive Explorer for cross-substance comparisons.
| Specimen | Window | Pattern | Caveat |
|---|---|---|---|
| Urine | 1–3 days | typical | Window approximate; chronic exposure may extend slightly. |
| Saliva | 1–48 hours | typical | Oral fluid window short. |
| Blood | 1–24 hours | typical | Very short plasma half-life. |
Ranges are approximate and vary by individual physiology, hydration, dose, frequency of use, and lab cutoff. They are not predictive of whether someone will "pass" a test.
About Fentanyl
A short-acting, highly potent synthetic μ-opioid receptor agonist. Drug-test detection targets the parent compound and its primary metabolite norfentanyl; immunoassay cross-reactivity to its many analogs (e.g., carfentanil) is variable.
Key analytes / metabolites detected
- Norfentanyl
Common cross-reactants (immunoassay-stage)
The following can affect screening immunoassay results and are typically resolved by mass-spectrometry confirmation and MRO review:
- Not commonly cross-reactive at immunoassay screening cutoffs
Appears in panels
Confirmation method
LC-MS/MS is the standard confirmation method for Fentanyl.
Sources & references
drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.